Novel Use of Botulinum Toxin in Long-Standing Adductor-Related Groin Pain: A Case Series.


Journal

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine
ISSN: 1536-3724
Titre abrégé: Clin J Sport Med
Pays: United States
ID NLM: 9103300

Informations de publication

Date de publication:
01 11 2022
Historique:
received: 01 09 2021
accepted: 28 07 2022
pubmed: 8 9 2022
medline: 3 11 2022
entrez: 7 9 2022
Statut: ppublish

Résumé

Adductor-related groin pain (ARGP) is the most common groin injury in athletes. If conservative treatment fails, then adductor tenotomy to relieve tension can be considered. The use of botulinum toxin A (BoNT-A) has shown good results in other musculoskeletal pathologies. Assess the effectiveness of BoNT-A injections in ARGP in cases where usual treatment has failed. Retrospective cohort study. Orthopedic Medicine and Rehabilitation Unit, University of Bordeaux. Fifty patients treated by BoNT-A injection in ARGP after failure of medical and/or surgical treatment were included in this study. One or several adductor muscles were injected with BoNT-A, according to clinical evaluation using ultrasound and electrical stimulation guidance. Patients were followed up at 1, 3, 6, and 12 months. The primary assessment criterion was the improvement of Hip and Groin Outcome Score subscales at day 30. Secondary outcomes included pain intensity and impact on sport, work, and quality of life (QoL), the Blazina scale, and side effects. All the first 50 injected patients (45 male and 5 female patients) were included. A significant improvement was noted regarding the majority of Hip and Groin Outcome Score subscales at day 30 ( P < 0.05). Pain intensity and its impacts were both significantly reduced ( P < 0.001): less sport and professional disability and lower impact on QoL. Severity of symptoms assessed by the Blazina scale was significantly reduced ( P < 0.001). The improvements remained significant until 1-year postinjection. BoNT-A is promising as a new treatment for ARGP but should be fully assessed in a randomized controlled trial.

Sections du résumé

BACKGROUND
Adductor-related groin pain (ARGP) is the most common groin injury in athletes. If conservative treatment fails, then adductor tenotomy to relieve tension can be considered. The use of botulinum toxin A (BoNT-A) has shown good results in other musculoskeletal pathologies.
OBJECTIVE
Assess the effectiveness of BoNT-A injections in ARGP in cases where usual treatment has failed.
DESIGN
Retrospective cohort study.
SETTING
Orthopedic Medicine and Rehabilitation Unit, University of Bordeaux.
PARTICIPANTS
Fifty patients treated by BoNT-A injection in ARGP after failure of medical and/or surgical treatment were included in this study.
INTERVENTIONS
One or several adductor muscles were injected with BoNT-A, according to clinical evaluation using ultrasound and electrical stimulation guidance. Patients were followed up at 1, 3, 6, and 12 months.
MAIN OUTCOME MEASURES
The primary assessment criterion was the improvement of Hip and Groin Outcome Score subscales at day 30. Secondary outcomes included pain intensity and impact on sport, work, and quality of life (QoL), the Blazina scale, and side effects.
RESULTS
All the first 50 injected patients (45 male and 5 female patients) were included. A significant improvement was noted regarding the majority of Hip and Groin Outcome Score subscales at day 30 ( P < 0.05). Pain intensity and its impacts were both significantly reduced ( P < 0.001): less sport and professional disability and lower impact on QoL. Severity of symptoms assessed by the Blazina scale was significantly reduced ( P < 0.001). The improvements remained significant until 1-year postinjection.
CONCLUSIONS
BoNT-A is promising as a new treatment for ARGP but should be fully assessed in a randomized controlled trial.

Identifiants

pubmed: 36070357
doi: 10.1097/JSM.0000000000001066
pii: 00042752-202211000-00003
doi:

Substances chimiques

Botulinum Toxins, Type A EC 3.4.24.69

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

567-573

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Morelli V, Smith V. Groin injuries in athletes. Am Fam Physician. 2001;64:1405–1414.
Weir A, Brukner P, Delahunt E, et al. Doha agreement meeting on terminology and definitions in groin pain in athletes. Br J Sports Med. 2015;49:768–774.
Holmich P. Long-standing groin pain in sportspeople falls into three primary patterns, a “clinical entity” approach: a prospective study of 207 patients. Br J Sports Med. 2007;41:247–252.
Rankin AT, Bleakley CM, Cullen M. Hip joint pathology as a leading cause of groin pain in the sporting population: a 6-year review of 894 cases. Am J Sports Med. 2015;43:1698–1703.
Taylor R, Vuckovic Z, Mosler A, et al. Multidisciplinary assessment of 100 athletes with groin pain using the doha agreement: high prevalence of adductor-related groin pain in conjunction with multiple causes. Clin J Sport Med. 2018;28:364–369.
Serner A, Van Eijck CH, Beumer BR, et al. Study quality on groin injury management remains low: a systematic review on treatment of groin pain in athletes. Br J Sports Med. 2015;49:813.
Weir A, Jansen J, van Keulen J, et al. Short and mid-term results of a comprehensive treatment program for longstanding adductor-related groin pain in athletes: a case series. Phys Ther Sport. 2010;11:99–103.
Hölmich P, Uhrskou P, Ulnits L, et al. Effectiveness of active physical training as treatment for long-standing adductor-related groin pain in athletes: randomised trial. Lancet. 1999;353:439–443.
Weir A, Jansen JACG, van de Port IGL, et al. Manual or exercise therapy for long-standing adductor-related groin pain: a randomised controlled clinical trial. Man Ther. 2011;16:148–154.
Schilders E, Dimitrakopoulou A, Cooke M, et al. Effectiveness of a selective partial adductor release for chronic adductor-related groin pain in professional athletes. Am J Sports Med. 2013;41:603–607.
Akermark C, Johansson C. Tenotomy of the adductor longus tendon in the treatment of chronic groin pain in athletes. Am J Sports Med. 1992;20:640–643.
Atkinson HDE, Johal P, Falworth MS, et al. Adductor tenotomy: its role in management of sports-related chronic groin pain. Arch Orthop Trauma Surg. 2010;130:965–970.
Roberston IJ., Curran C, McCaffrey N, et al. Adductor tenotomy in the management of groin pain in athletes. Int J Sports Med. 2011;32:45–48.
King E, Ward J, Small L, et al. Athletic groin pain: a systematic review and meta-analysis of surgical versus physical therapy rehabilitation outcomes. Br J Sports Med. 2015;49:1447–1451.
Morré HH, Keizer SB, Van Os J. Treatment of chronic tennis elbow with botulinum toxin. Lancet. 1997;349:1746.
Oskarsson E, Piehl Aulin K, Gustafsson BE, et al. Improved intramuscular blood flow and normalized metabolism in lateral epicondylitis after botulinum toxin treatment. Scand J Med Sci Sports. 2009;19:323–328.
Creuzé A, Petit H, de Sèze M. Short-term effect of low-dose, electromyography-guided botulinum toxin a injection in the treatment of chronic lateral epicondylar tendinopathy: a randomized, double-blinded study. J Bone Joint Surg Am. 2018;100:818–826.
Michel F, Decavel P, Toussirot E, et al. Piriformis muscle syndrome: diagnostic criteria and treatment of a monocentric series of 250 patients. Ann Phys Rehabil Med. 2013;56: 371–383.
Isner-Horobeti ME, Dufour SP, Blaes C, et al. Intramuscular pressure before and after botulinum toxin in chronic exertional compartment syndrome of the leg: a preliminary study. Am J Sports Med. 2013;41:2558–2566.
Schwartz AG, Lipner JH, Pasteris JD, et al. Muscle loading is necessary for the formation of a functional tendon enthesis. Bone. 2013;55:44–51.
Pellett S, Yaksh TL, Ramachandran R. Current status and future directions of botulinum neurotoxins for targeting pain processing. Toxins. 2015;7:4519–4563.
Cui M, Khanijou S, Rubino J, et al. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain. 2004;107:125–133.
Alfredson H, Lorentzon R. Intratendinous glutamate levels and eccentric training in chronic Achilles tendinosis: a prospective study using microdialysis technique. Knee Surg Sports Traumatol Arthrosc. 2003;11:196–199.
Lucioni A, Bales GT, Lotan TL, et al. Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int. 2008;101:366–370.
Thorborg K, Holmich P, Christensen R, et al. The Copenhagen Hip and Groin Outcome Score (HAGOS): development and validation according to the COSMIN checklist. Br J Sports Med. 2011;45:478–491.
Blazina ME, Kerlan RK, Jobe FW, et al. Jumper's knee. Orthop Clin North Am. 1973;4:665–678.
Thomeé R, Jonasson P, Thorborg K, et al. Cross-cultural adaptation to Swedish and validation of the Copenhagen Hip and Groin Outcome Score (HAGOS) for pain, symptoms and physical function in patients with hip and groin disability due to femoro-acetabular impingement. Knee Surg Sports Traumatol Arthrosc. 2014;22;835–842.
Hyman N, Barnes M, Bhakta B, et al. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurf Psychiatry. 2000;68:707–712.
Robinson P, Barron DA, Parsons W, et al. Adductor-related groin pain in athletes: correlation of MR imaging with clinical findings. Skeletal Radiol. 2004;33:451–457.
Reuter I, Lorbach O, Mehnert S, et al. Botulinum toxin improves reduced dorsiflexion after Achilles tendon surgery. Knee Surg Sports Traumatol Arthrosc. 2010;18:265–268.
Tuzuner S, Özkan Ö, Erin N, et al. Effects of botulinum toxin A injection on Healing and tensile strength of ruptured rabbit achilles tendons: Ann Plast Surg. 2015;74:496–500.
Kubat WD, Rekant M. Botulinum toxin use as an adjunctive modality in a patient with multiple flexor tendon ruptures. Hand. 2008;3:237–239.
Davis JA, Stringer MD, Woodley SJ. New insights into the proximal tendons of adductor longus, adductor brevis and gracilis. Br J Sports Med. 2012;46:871–876.
Strauss EJ, Campbell K, Bosco JA. Analysis of the cross-sectional area of the adductor longus tendon: a descriptive anatomic study. Am J Sports Med. 2007;35:996–999.
Pesquer L, Reboul G, Silvestre A, et al. Imaging of adductor-related groin pain. Diagn Interv Imaging. 2015;96:861–869.

Auteurs

Alexandre Creuzé (A)

Centre Hospitalier Universitaire de Bordeaux, Service de Médecine Physique et de Réadaptation, Unité de Médecine Orthopédique et Sportive, Bordeaux, Aquitaine, France.
Clinique du Sport de Bordeaux Mérignac, Mérignac, Nouvelle-Aquitaine, France.

Thomas Fok-Cheong (T)

Centre Hospitalier Universitaire de Bordeaux, Service de Médecine Physique et de Réadaptation, Unité de Médecine Orthopédique et Sportive, Bordeaux, Aquitaine, France.
GHSR, Unité de Médecine du Sport, Saint Pierre La Reunion, Reunion.

Adam Weir (A)

Erasmus MC Center for Groin Injuries, Department of Orthopaedics, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.
Aspetar Sports Groin Pain Centre, Aspetar Orthopaedic and Sports Hospital, Doha, Qatar.
Sport Medicine and Exercise Clinic Haarlem (SBK), Haarlem, The Netherlands; and.

Philippe Bordes (P)

Centre Hospitalier Universitaire de Bordeaux, Service de Médecine Physique et de Réadaptation, Unité de Médecine Orthopédique et Sportive, Bordeaux, Aquitaine, France.

Gilles Reboul (G)

Clinique du Sport de Bordeaux Mérignac, Mérignac, Nouvelle-Aquitaine, France.

Bertrand Glize (B)

Centre Hospitalier Universitaire de Bordeaux, Service de Médecine Physique et de Réadaptation, Unité de Médecine Orthopédique et Sportive, Bordeaux, Aquitaine, France.
University of Bordeaux Faculty of Medical Sciences, u1219 Inserm, Bordeaux, Aquitaine, France.

Mathieu de Seze (M)

Centre Hospitalier Universitaire de Bordeaux, Service de Médecine Physique et de Réadaptation, Unité de Médecine Orthopédique et Sportive, Bordeaux, Aquitaine, France.
University of Bordeaux Faculty of Medical Sciences, u1219 Inserm, Bordeaux, Aquitaine, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH